C19orf38 and leiomyoma: To study this further, we performed supervised hierarchical clustering analysis using the HMGA1 gene and six previously highlighted biomarkers for HMGA2‐positive leiomyomas (HMGA2, IGF2BP2, CCND2, IL11RA, C19orf38, and PLAG1).11